OBJECTIVES: The effect of acute exacerbation of chronic obstructive pulmonary disease (COPD) on brachial artery flow-mediated dilation (FMD) has not been examined. The aim of this study was to assess the endothelial function of COPD patients during acute exacerbations. STUDY DESIGN: The study included 30 consecutive patients (8 women, 22 men; mean age 64.2+/-10.9 years) who experienced acute exacerbation of COPD, defined according to the Anthonisen criteria (increased dyspnea, sputum, and sputum purulence). All patients received the same antibiotic and bronchodilator treatment. Endothelial function was assessed by brachial artery ultrasonography within the first 48 hours and after complete resolution of exacerbation symptoms. Flow-mediated dilation was defined as both the maximum absolute and maximum percentage changes in the vessel diameter during reactive hyperemia. The results were compared with those of 20 age-and sex-matched controls without COPD. RESULTS: The patient and control groups were similar in terms of age, gender, hypertension, diabetes, hyperlipidemia, coronary artery disease, heart rate, and blood pressure. Parameters of FMD during acute exacerbation were significantly lower than those obtained after recovery (absolute change: 0.23+/-0.12 mm vs. 0.38+/-0.17 mm, p<0.001; percentage change: 6.44+/-3.99% vs. 10.42+/-4.86%, p<0.001) and than those of the control group (absolute change: 0.36+/-0.13 mm, p=0.001; percentage change: 9.77+/-3.83%, p=0.003). Flow-mediated dilation increased significantly after recovery, yielding similar values to those of the controls. Improvements in FMD were significant in both sexes. CONCLUSION: Acute COPD exacerbation is associated with worsening endothelial function, increasing the risk for cardiovascular morbidity.
OBJECTIVES: The effect of acute exacerbation of chronic obstructive pulmonary disease (COPD) on brachial artery flow-mediated dilation (FMD) has not been examined. The aim of this study was to assess the endothelial function of COPDpatients during acute exacerbations. STUDY DESIGN: The study included 30 consecutive patients (8 women, 22 men; mean age 64.2+/-10.9 years) who experienced acute exacerbation of COPD, defined according to the Anthonisen criteria (increased dyspnea, sputum, and sputum purulence). All patients received the same antibiotic and bronchodilator treatment. Endothelial function was assessed by brachial artery ultrasonography within the first 48 hours and after complete resolution of exacerbation symptoms. Flow-mediated dilation was defined as both the maximum absolute and maximum percentage changes in the vessel diameter during reactive hyperemia. The results were compared with those of 20 age-and sex-matched controls without COPD. RESULTS: The patient and control groups were similar in terms of age, gender, hypertension, diabetes, hyperlipidemia, coronary artery disease, heart rate, and blood pressure. Parameters of FMD during acute exacerbation were significantly lower than those obtained after recovery (absolute change: 0.23+/-0.12 mm vs. 0.38+/-0.17 mm, p<0.001; percentage change: 6.44+/-3.99% vs. 10.42+/-4.86%, p<0.001) and than those of the control group (absolute change: 0.36+/-0.13 mm, p=0.001; percentage change: 9.77+/-3.83%, p=0.003). Flow-mediated dilation increased significantly after recovery, yielding similar values to those of the controls. Improvements in FMD were significant in both sexes. CONCLUSION: Acute COPD exacerbation is associated with worsening endothelial function, increasing the risk for cardiovascular morbidity.
Authors: Stephen J Ives; Gwenael Layec; Corey R Hart; Joel D Trinity; Jayson R Gifford; Ryan S Garten; Melissa A H Witman; Jacob R Sorensen; Russell S Richardson Journal: J Appl Physiol (1985) Date: 2020-04-23
Authors: Pasquale Ambrosino; Roberta Lupoli; Salvatore Iervolino; Alberto De Felice; Nicola Pappone; Antonio Storino; Matteo Nicola Dario Di Minno Journal: Intern Emerg Med Date: 2017-06-07 Impact factor: 3.397
Authors: Stephen J Ives; Ryan A Harris; Melissa A H Witman; Anette S Fjeldstad; Ryan S Garten; John McDaniel; D Walter Wray; Russell S Richardson Journal: Hypertension Date: 2013-12-09 Impact factor: 10.190
Authors: David M G Halpin; Marc Decramer; Bartolome Celli; Steven Kesten; Inge Leimer; Donald P Tashkin Journal: Lung Date: 2011-06-16 Impact factor: 2.584
Authors: Paula Rodriguez-Miguelez; Nichole Seigler; Leon Bass; Thomas A Dillard; Ryan A Harris Journal: Int J Chron Obstruct Pulmon Dis Date: 2015-09-16
Authors: Kannayiram Alagiakrishnan; Michael Brokop; Andrew Cave; Brian H Rowe; Eric Wong; Ambikaipakan Senthilselvan Journal: J Clin Med Res Date: 2016-02-27
Authors: Andreas Scherr; Desiree M Schumann; Meropi Karakioulaki; Léo Franchetti; Werner Strobel; Michael Zellweger; Michael Tamm; Daiana Stolz Journal: Respir Res Date: 2020-04-20
Authors: Marieta P Theodorakopoulou; Maria Eleni Alexandrou; Dimitra Rafailia Bakaloudi; Georgia Pitsiou; Ioannis Stanopoulos; Theodoros Kontakiotis; Afroditi K Boutou Journal: ERJ Open Res Date: 2021-06-28